Safety and Efficacy of IBI306 in Chinese Subjects With Non-familial Hypercholesterolemia

NCT04289285 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

804

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: IBI306 450mg SC Q4W
DRUG: Placebo SC Q4W
DRUG: IBI306 600mg SC Q6W
OTHER: Placebo SC Q6W

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.